Search

Ajovy

Ajovy

fremanezumab

Manufacturer:

Teva

Distributor:

Zuellig
NEW Brand Resources
Concise Prescribing Info
Contents
Fremanezumab
Indications/Uses
Migraine prophylaxis in adults w/ at least 4 migraine days per mth.
Click to view Ajovy detailed prescribing information
Dosage/Direction for Use
SC 225 mg once mthly or 675 mg every 3 mth.
Click to view Ajovy detailed prescribing information
Overdosage
View Ajovy overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity.
Click to view Ajovy detailed prescribing information
Special Precautions
Discontinue in case of hypersensitivity reactions. Do not administer by IV or IM route. Do not inject to tender, bruised, red, or indurated areas. Alternate inj sites for multiple inj. Patients w/ major CV diseases. Preferable to avoid use during pregnancy. Lactation.
Click to view Ajovy detailed prescribing information
Adverse Reactions
Inj site pain, induration, erythema, pruritus.
Click to view Ajovy detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Ajovy detailed prescribing information
Storage
View Ajovy storage conditions for details to ensure optimal shelf-life.
Description
View Ajovy description for details of the chemical structure and excipients (inactive components).
Action
View Ajovy mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD03 - fremanezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Ajovy soln for inj 225 mg/1.5 mL
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in